Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna King

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Australasian Journal on Ageing|July 4, 2026
Hearing Loss and Modifiable Dementia Risk Factors in Adults Aged 50 Years or Older Living in Tasmania, AustraliaMohammad Shoaib Hamrah, Kathleen Doherty, Aidan Bindoff, et al.
Science Advances|July 8, 2016
Tumor-homing peptides as tools for targeted delivery of payloads to the placentaAnna King, Cornelia Ndifon, Sylvia Lui, et al.
Molecular Microbiology|July 31, 2025
Homeostatic Influence of Fig4 Outside of the Fab1-Vac14-Fig4 Complex in Saccharomyces cerevisiaeHannah E Reeves, Anna King, Imran Khan, et al.
Open Heart|July 2, 2020
Research priorities in advanced heart failure: James Lind alliance priority setting partnershipClare J Taylor, Alyson L Huntley, John Burden, et al.
Molecular Cancer Therapeutics|July 13, 2021
Valency of HER2 Targeting Antibodies Influences Tumor Cell Internalization and PenetrationMadeleine K Ramos, Danielle Mandikian, Lauren N Sermeño, et al.
BMC Cancer|June 29, 2026
Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS studyGanesh Radhakrishna, Christopher M Jones, C William Bleaney, et al.
Bioorganic & Medicinal Chemistry|September 12, 2013
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseasesDavid A Sandham, Nicola Arnold, Heinrich Aschauer, et al.
Journal of Medicinal Chemistry|May 24, 2021
Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseDarren Le Grand, Martin Gosling, Urs Baettig, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Australasian Journal on Ageing|July 4, 2026
Hearing Loss and Modifiable Dementia Risk Factors in Adults Aged 50 Years or Older Living in Tasmania, AustraliaMohammad Shoaib Hamrah, Kathleen Doherty, Aidan Bindoff, et al.
Science Advances|July 8, 2016
Tumor-homing peptides as tools for targeted delivery of payloads to the placentaAnna King, Cornelia Ndifon, Sylvia Lui, et al.
Molecular Microbiology|July 31, 2025
Homeostatic Influence of Fig4 Outside of the Fab1-Vac14-Fig4 Complex in Saccharomyces cerevisiaeHannah E Reeves, Anna King, Imran Khan, et al.
Open Heart|July 2, 2020
Research priorities in advanced heart failure: James Lind alliance priority setting partnershipClare J Taylor, Alyson L Huntley, John Burden, et al.
Molecular Cancer Therapeutics|July 13, 2021
Valency of HER2 Targeting Antibodies Influences Tumor Cell Internalization and PenetrationMadeleine K Ramos, Danielle Mandikian, Lauren N Sermeño, et al.
BMC Cancer|June 29, 2026
Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS studyGanesh Radhakrishna, Christopher M Jones, C William Bleaney, et al.
Bioorganic & Medicinal Chemistry|September 12, 2013
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseasesDavid A Sandham, Nicola Arnold, Heinrich Aschauer, et al.
Journal of Medicinal Chemistry|May 24, 2021
Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseDarren Le Grand, Martin Gosling, Urs Baettig, et al.
Pageof 5